146 related articles for article (PubMed ID: 34227174)
1. Tumor contact length of prostate cancer determined by a three-dimensional method on multiparametric magnetic resonance imaging predicts extraprostatic extension and biochemical recurrence.
Miyamoto S; Goto K; Honda Y; Terada H; Fujii S; Ueno T; Fukuoka K; Sekino Y; Kitano H; Ikeda K; Hieda K; Inoue S; Hayashi T; Teishima J; Takeshima Y; Yasui W; Awai K; Matsubara A
Int J Urol; 2021 Oct; 28(10):1012-1018. PubMed ID: 34227174
[TBL] [Abstract][Full Text] [Related]
2. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
Somford DM; Hamoen EH; Fütterer JJ; van Basten JP; Hulsbergen-van de Kaa CA; Vreuls W; van Oort IM; Vergunst H; Kiemeney LA; Barentsz JO; Witjes JA
J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
[TBL] [Abstract][Full Text] [Related]
3. Staging Accuracy of Multiparametric Magnetic Resonance Imaging in Caucasian and African American Men Undergoing Radical Prostatectomy.
Falagario UG; Ratnani P; Lantz A; Jambor I; Dovey Z; Verma A; Treacy PJ; Sobotka S; Martini A; Bashorun H; Ashan M; Wagaskar VG; Lewis S; Cormio L; Carrieri G; Kyprianou N; Mohamed N; Tewari A
J Urol; 2020 Jul; 204(1):82-90. PubMed ID: 31977261
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen level, biopsy grade group, and tumor-capsular contact length on magnetic resonance imaging are independently associated with an extraprostatic extension.
Washino S; Ito K; Miyagawa T
Int J Urol; 2022 Dec; 29(12):1455-1461. PubMed ID: 36001632
[TBL] [Abstract][Full Text] [Related]
5. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Disease-A Risk Model for Patient-tailored Risk Stratification When Planning Radical Prostatectomy.
Nyarangi-Dix J; Wiesenfarth M; Bonekamp D; Hitthaler B; Schütz V; Dieffenbacher S; Mueller-Wolf M; Roth W; Stenzinger A; Duensing S; Roethke M; Teber D; Schlemmer HP; Hohenfellner M; Radtke JP
Eur Urol Focus; 2020 Nov; 6(6):1205-1212. PubMed ID: 30477971
[TBL] [Abstract][Full Text] [Related]
6. Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology.
Tan N; Shen L; Khoshnoodi P; Alcalá HE; Yu W; Hsu W; Reiter RE; Lu DY; Raman SS
J Urol; 2018 May; 199(5):1218-1223. PubMed ID: 29128577
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer staging: correlation between ultrasound determined tumor contact length and pathologically confirmed extraprostatic extension.
Ukimura O; Troncoso P; Ramirez EI; Babaian RJ
J Urol; 1998 Apr; 159(4):1251-9. PubMed ID: 9507847
[TBL] [Abstract][Full Text] [Related]
8. Tumor contact with prostate capsule on magnetic resonance imaging: A potential biomarker for staging and prognosis.
Kongnyuy M; Sidana A; George AK; Muthigi A; Iyer A; Ho R; Chelluri R; Mertan F; Frye TP; Su D; Merino MJ; Choyke PL; Wood BJ; Pinto PA; Turkbey B
Urol Oncol; 2017 Jan; 35(1):30.e1-30.e8. PubMed ID: 27567248
[TBL] [Abstract][Full Text] [Related]
9. Lesion size on prostate magnetic resonance imaging predicts adverse radical prostatectomy pathology.
Tonttila PP; Kuisma M; Pääkkö E; Hirvikoski P; Vaarala MH
Scand J Urol; 2018 Apr; 52(2):111-115. PubMed ID: 29291666
[TBL] [Abstract][Full Text] [Related]
10. Perineural invasion by prostate cancer on MR/US fusion targeted biopsy is associated with extraprostatic extension and early biochemical recurrence after radical prostatectomy.
Truong M; Rais-Bahrami S; Nix JW; Messing EM; Miyamoto H; Gordetsky JB
Hum Pathol; 2017 Aug; 66():206-211. PubMed ID: 28705708
[TBL] [Abstract][Full Text] [Related]
11. A multivariable analysis of clinical factors predicting for pathological features associated with local failure after radical prostatectomy for prostate cancer.
D'Amico AV; Whittington R; Malkowicz SB; Schnall M; Tomaszewski J; Schultz D; Kao G; VanArsdalen K; Wein A
Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):293-302. PubMed ID: 7928457
[TBL] [Abstract][Full Text] [Related]
12. The extent of biopsy involvement as an independent predictor of extraprostatic extension and surgical margin status in low risk prostate cancer: implications for treatment selection.
Gao X; Mohideen N; Flanigan RC; Waters WB; Wojcik EM; Leman CR
J Urol; 2000 Dec; 164(6):1982-6. PubMed ID: 11061896
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of magnetic resonance imaging determined tumor contact length for extracapsular extension of prostate cancer.
Baco E; Rud E; Vlatkovic L; Svindland A; Eggesbø HB; Hung AJ; Matsugasumi T; Bernhard JC; Gill IS; Ukimura O
J Urol; 2015 Feb; 193(2):466-72. PubMed ID: 25150643
[TBL] [Abstract][Full Text] [Related]
14. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.
Freedland SJ; Wieder JA; Jack GS; Dorey F; deKernion JB; Aronson WJ
J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Risk of Clinical Progression Utilizing Magnetic Resonance Imaging Findings of Locally Recurrent Prostate Cancer in Patients with Biochemical Recurrence following Radical Prostatectomy.
Tanaka T; Kawashima A; Rangel LJ; Schulte PJ; Froemming AT; King BF; Mynderse LA; Karnes RJ
J Urol; 2022 May; 207(5):1038-1047. PubMed ID: 34981952
[TBL] [Abstract][Full Text] [Related]
16. Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer.
Rayn KN; Bloom JB; Gold SA; Hale GR; Baiocco JA; Mehralivand S; Czarniecki M; Sabarwal VK; Valera V; Wood BJ; Merino MJ; Choyke P; Turkbey B; Pinto PA
J Urol; 2018 Nov; 200(5):1041-1047. PubMed ID: 29852182
[TBL] [Abstract][Full Text] [Related]
17. Biparametric Prostate Imaging Reporting and Data System version2 and International Society of Urological Pathology Grade Predict Biochemical Recurrence after Radical Prostatectomy.
Takeuchi N; Sakamoto S; Nishiyama A; Horikoshi T; Yamada Y; Iizuka J; Maimaiti M; Imamura Y; Kawamura K; Imamoto T; Komiya A; Ikehara Y; Akakura K; Ichikawa T
Clin Genitourin Cancer; 2018 Aug; 16(4):e817-e829. PubMed ID: 29576444
[TBL] [Abstract][Full Text] [Related]
18. Prediction of biochemical recurrence in prostate cancer patients who underwent prostatectomy using routine clinical prostate multiparametric MRI and decipher genomic score.
Jambor I; Falagario U; Ratnani P; Perez IM; Demir K; Merisaari H; Sobotka S; Haines GK; Martini A; Beksac AT; Lewis S; Pahikkala T; Wiklund P; Nair S; Tewari A
J Magn Reson Imaging; 2020 Apr; 51(4):1075-1085. PubMed ID: 31566845
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer: role of pretreatment multiparametric 3-T MRI in predicting biochemical recurrence after radical prostatectomy.
Park JJ; Kim CK; Park SY; Park BK; Lee HM; Cho SW
AJR Am J Roentgenol; 2014 May; 202(5):W459-65. PubMed ID: 24758681
[TBL] [Abstract][Full Text] [Related]
20. Predicting Pathological Tumor Size in Prostate Cancer Based on Multiparametric Prostate Magnetic Resonance Imaging and Preoperative Findings.
Pooli A; Johnson DC; Shirk J; Markovic D; Sadun TY; Sisk AE; Mohammadian Bajgiran A; Afshari Mirak S; Felker ER; Hughes AK; Raman SS; Reiter RE
J Urol; 2021 Feb; 205(2):444-451. PubMed ID: 33026934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]